Related Experiment Video
Updated: May 31, 2026

08:43
Metagenomic Analysis of Silage
Published on: January 13, 2017
Metagenomic biomarker discovery and explanation
Nicola Segata1, Jacques Izard, Levi Waldron
1Department of Biostatistics, 677 Huntington Avenue, Harvard School of Public Health, Boston, MA 02115, USA.
Genome Biology
|June 28, 2011
Summary
This study introduces a new method for metagenomic biomarker discovery, identifying microbial organisms, genes, or pathways that distinguish between different microbial communities. The approach is validated across multiple microbiomes and available online.
Area of Science:
- Microbiology
- Bioinformatics
- Computational Biology
Background:
- Metagenomics enables the study of microbial communities directly from environmental samples.
- Identifying specific microbial taxa, genes, or pathways that differentiate between sample groups is crucial for understanding community structure and function.
- Existing methods may face challenges in consistently identifying robust biomarkers across diverse microbial communities.
Purpose of the Study:
- To develop and validate a novel computational method for metagenomic biomarker discovery.
- To address the challenge of identifying consistent and significant differences between microbial communities.
- To provide a user-friendly tool for analyzing metagenomic data.
Main Methods:
- The study proposes a new class comparison method incorporating tests for biological consistency and effect size estimation.
- The method, named LEfSe (Linear Models for Expression Data), is designed for biomarker discovery in metagenomic datasets.
- Validation was performed on multiple microbiome datasets.
Main Results:
- The developed method successfully identified significant microbial biomarkers differentiating between sample groups in various microbiomes.
- Biological consistency and effect size metrics were effectively integrated to enhance biomarker reliability.
- The LEfSe method demonstrated robust performance in comparative metagenomic analyses.
Conclusions:
- The new metagenomic biomarker discovery method provides a reliable approach for identifying differentiating organisms, genes, or pathways.
- The method's validation across diverse microbiomes confirms its broad applicability.
- An online interface is available, facilitating the use of this tool in metagenomic research.
Related Concept Videos
Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...
Modern Molecular Taxonomy
Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
